Ribon Therapeutics, Inc. announced it raised $25.2 Million in an initial filing from an offering of $60.2 Million

Jun 14, 2021•over 4 years ago

Amount Raised

$25.2 Million

Cambridge

Company Information

Company

Ribon Therapeutics, Inc.

Location

Cambridgepark Drive

Cambridge, Maryland, United States

About

Ribon is a clinical-stage biotechnology company dedicated to the discovery and development of first-in-class small molecule inhibitors to block the fundamental ability of cancer cells to survive under stress.

Related People

20 contacts

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Ribon Therapeutics, Inc. announced it raised $25.2 Million in an initial filing from an offering of $60.2 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information